Deep-learning Integration of Histopathology and Proteogenomics at a Pan-cancer Level - Resubmission
Deep-learning Integration of Histopathology and Proteogenomics at a Pan-cancer Level - Resubmission
批准号:
10606760
负责人:
Joshua Wang
金额:
$4.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-03-01 至 2025-06-30
关键词:
AddressAntibodiesAntigen PresentationArchitectureAutomobile DrivingBiologicalBiomedical ResearchBiopsyCancer PrognosisCellular MorphologyClinicClinicalCollaborationsCommunitiesComplementComplete Blood CountComputing MethodologiesDNA Sequence AlterationDataData SetDecision MakingDiagnosisDiseaseDisease-Free SurvivalDisparateDreamsEndometrial CarcinomaGenesGenetic TranscriptionGlioblastomaHematologyHistologicHistologyHistopathologyImageImmunohistochemistryImmunophenotypingIndividualIntuitionKRAS2 geneKnowledgeKnowledge DiscoveryLearningMalignant NeoplasmsMalignant neoplasm of lungMeasurementMedicalMethodsMitoticModelingMolecularMolecular ProfilingMorphologyMultiomic DataMutationNational Cancer InstituteNeural Network SimulationNuclearOutcomePIK3CA genePathologicPathologistPathologyPathway interactionsPatientsPatternPerformanceProcessPrognosisProteinsProteomicsRegulatory PathwayResearchResolutionRoleStainsTP53 geneTissuesTrainingTrustTumor BiologyTumor PathologyTumor stageUrineValidationVisualVisualizationWorkZFHX3 genecancer therapycancer typeclinical practiceclinical predictorsconvolutional neural networkdata integrationdeep learningdeep learning modeldensitydiagnostic biomarkerdiagnostic tooldiagnostic valuedifferential expressionillness lengthimaging platformimmune cell infiltrateimprovedinterestmachine learning modelmachine learning predictionmultiple omicsnovelpersonalized diagnosticspredict clinical outcomepredictive signatureproteogenomicsreconstitutiontooltranscriptomicstumortumor heterogeneitytumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Discovering and understanding novel pathological features that correlate with proteogenomics is crucial in
improving and streamlining cancer prognosis and treatment. Currently, biomedical research efforts to predict
cancer outcomes rely on sequencing approaches not readily accessible in a clinical setting. Instead, clinicians
frequently rely on histopathology images to visually assess for aberrant changes to tissue morphology.
Subsequently, a tool to infer clinical and molecular signatures directly from histopathology images would harness
the power of omics research with the feasibility of image-based diagnosis.
Histopathology imaging data is still vastly underutilized in the quest to better understand tumor biology, largely
because of inadequate tools for analysis and data integration. To identify pan-cancer hallmarks and conserved
pathways of tumorigenesis, I therefore propose to develop multi-resolution deep convolutional neural network
(CNN) models across 10 different cancer types and predict clinical annotations, histology outcomes, and critical
mutations based on tumor histopathology images (Aim 1). Through our lab’s collaboration with the National
Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC), we have access to multi-omics,
clinical, and histopathologic data obtained from 1,602 patients. In addition, to understand the biological
mechanisms driving morphology changes, I propose to develop computational methods that integrate
transcriptomic and proteomic expression datasets with imaging to facilitate pathway-level knowledge discovery
(Aim 2). Our proposal is the first to correlate expression perturbations with morphology patterns and identify
enriched canonical pathways directly from histopathology images. Importantly, this proposal aims to connect
scientific efforts of biomedical research with the diagnostic tools of clinicians to expand diagnostic power and
improve clinical practice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金